NASDAQ · OPCH
Healthcare · Medical - Care Facilities
$31.77
Down-$0.07 (-0.20%)
Updated Nov 4, 2026, 7:38 PM
SID Score
5.6/10
Composite research score
Smart Money
58/100
Neutral
Price performance · OPCH
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
OPCH closed at $31.77 after 21 trading sessions, up 2.48% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $31.68 | $31.81 | $31.64 | $31.77 | 3.38M |
| Nov 2, 2026 | $31.87 | $31.88 | $31.665 | $31.69 | 2.68M |
| Oct 30, 2026 | $31.85 | $31.90 | $31.77 | $31.83 | 4.23M |
| Oct 29, 2026 | $31.86 | $31.88 | $31.55 | $31.85 | 11.82M |
| Oct 28, 2026 | $31.30 | $31.325 | $31.255 | $31.29 | 2.88M |
| Oct 27, 2026 | $31.28 | $31.30 | $31.24 | $31.29 | 2.51M |
| Oct 26, 2026 | $31.27 | $31.285 | $31.22 | $31.23 | 2.05M |
| Oct 23, 2026 | $31.31 | $31.33 | $31.22 | $31.22 | 2.65M |
| Oct 22, 2026 | $31.33 | $31.355 | $31.29 | $31.29 | 1.93M |
| Oct 21, 2026 | $31.29 | $31.36 | $31.255 | $31.29 | 2.22M |
| Oct 20, 2026 | $31.27 | $31.38 | $31.20 | $31.36 | 2.75M |
| Oct 19, 2026 | $31.22 | $31.28 | $31.13 | $31.21 | 2.97M |
| Oct 16, 2026 | $31.24 | $31.35 | $31.175 | $31.20 | 2.85M |
| Oct 15, 2026 | $31.155 | $31.24 | $31.12 | $31.22 | 4.12M |
| Oct 14, 2026 | $31.11 | $31.15 | $31.09 | $31.12 | 4.93M |
| Oct 13, 2026 | $31.13 | $31.17 | $31.09 | $31.10 | 5.01M |
| Oct 12, 2026 | $31.08 | $31.15 | $31.07 | $31.10 | 4.84M |
| Oct 9, 2026 | $31.05 | $31.11 | $31.0301 | $31.07 | 6.21M |
| Oct 8, 2026 | $31.05 | $31.085 | $31.01 | $31.05 | 9.66M |
| Oct 7, 2026 | $31.03 | $31.06 | $30.99 | $31.01 | 19.35M |
| Oct 6, 2026 | $31.04 | $31.11 | $30.965 | $31.00 | 65.08M |
The latest Smart Investors Daily articles mentioning OPCH.
Company
Market Activity
Research & News
OPCH research
Company profile and research snapshot.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 9, 2026 | UBS | Neutral | — |
| Oct 7, 2026 | Citizens | Market Perform | — |
| Oct 7, 2026 | Barrington Research | Market Perform | — |
| Oct 7, 2026 | Jefferies | Hold | — |
| Oct 7, 2026 | William Blair | Market Perform | — |
No generated briefing is available yet.
Yahoo · Oct 29, 2026
DaVita HealthCare (DVA) delivered earnings and revenue surprises of +1.06% and +1.34%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · Oct 15, 2026
Investing.com -- TD Cowen maintains a positive outlook on the pharmacy benefit manager (PBM) and pharmacy sector heading into the third quarter, citing healthy specialty pharmacy trends and favorable managed care organization commentary at recent conferences. The bank highlights attractive valuations and anticipated earnings beats across several names in the group.
ChartMill · Oct 15, 2026
Option Care Health (OPCH) passes a quality screen with strong ROIC, EBIT growth and cash flow. See the full fundamental breakdown and risks.
SeekingAlpha · Oct 13, 2026
McKesson stock is up 170% since 2022. Learn whatâs driving growth, how recent M&A reshapes its portfolio, and if valuation limits upside.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning OPCH.
